King Martin S, Sharpley Mark S, Hirst Judy
Medical Research Council Dunn Human Nutrition Unit, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, UK.
Biochemistry. 2009 Mar 10;48(9):2053-62. doi: 10.1021/bi802282h.
ubiquinone oxidoreductase (complex I) from bovine heart mitochondria is a complicated, energy-transducing, membrane-bound enzyme that contains 45 different subunits, a non-covalently bound flavin mononucleotide, and eight iron-sulfur clusters. The mechanisms of NADH oxidation and intramolecular electron transfer by complex I are gradually being defined, but the mechanism linking ubiquinone reduction to proton translocation remains unknown. Studies of ubiquinone reduction by isolated complex I are problematic because the extremely hydrophobic natural substrate, ubiquinone-10, must be substituted with a relatively hydrophilic analogue (such as ubiquinone-1). Hydrophilic ubiquinones are reduced by an additional, non-energy-transducing pathway (which is insensitive to inhibitors such as rotenone and piericidin A). Here, we show that inhibitor-insensitive ubiquinone reduction occurs by a ping-pong type mechanism, catalyzed by the flavin mononucleotide cofactor in the active site for NADH oxidation. Moreover, semiquinones produced at the flavin site initiate redox cycling reactions with molecular oxygen, producing superoxide radicals and hydrogen peroxide. The ubiquinone reactant is regenerated, so the NADH:Q reaction becomes superstoichiometric. Idebenone, an artificial ubiquinone showing promise in the treatment of Friedreich's Ataxia, reacts at the flavin site. The factors which determine the balance of reactivity between the two sites of ubiquinone reduction (the energy-transducing site and the flavin site) and the implications for mechanistic studies of ubiquinone reduction by complex I are discussed. Finally, the possibility that the flavin site in complex I catalyzes redox cycling reactions with a wide range of compounds, some of which are important in pharmacology and toxicology, is discussed.
来自牛心线粒体的NADH:泛醌氧化还原酶(复合体I)是一种复杂的、能量转换的膜结合酶,它含有45种不同的亚基、一个非共价结合的黄素单核苷酸和八个铁硫簇。复合体I进行NADH氧化和分子内电子转移的机制正在逐步明确,但泛醌还原与质子转运之间的联系机制仍然未知。对分离出的复合体I进行泛醌还原的研究存在问题,因为极疏水的天然底物泛醌-10必须被相对亲水的类似物(如泛醌-1)替代。亲水泛醌通过另一条非能量转换途径被还原(该途径对鱼藤酮和杀粉蝶菌素A等抑制剂不敏感)。在此,我们表明抑制剂不敏感的泛醌还原通过乒乓型机制发生,由NADH氧化活性位点中的黄素单核苷酸辅因子催化。此外,在黄素位点产生的半醌与分子氧引发氧化还原循环反应,产生超氧自由基和过氧化氢。泛醌反应物得以再生,因此NADH:Q反应变得超化学计量。艾地苯醌是一种在治疗弗里德赖希共济失调方面显示出前景的人工合成泛醌,它在黄素位点发生反应。讨论了决定泛醌还原两个位点(能量转换位点和黄素位点)之间反应活性平衡的因素以及对复合体I泛醌还原机制研究的影响。最后,讨论了复合体I中的黄素位点催化与多种化合物发生氧化还原循环反应的可能性,其中一些化合物在药理学和毒理学中很重要。